TCGA-55-A494, TCGA-55-A494SENT_1,"UUID :6 FB7C18D-27D8-4 :04 - B8F8-AA7EA16F8C8A","{UUID,:6,FB7C18D-27D8-4,:04,-,B8F8-AA7EA16F8C8A}","{uuid,:6,fb7c18d-27d8-4,:04,-,b8f8-aa7ea16f8c8a}","{NN,CD,NN,CD,:,NN}","{0,1,1,3,0,3}","{}"
TCGA-55-A494, TCGA-55-A494SENT_2,"TCGA-55-A4-94 .","{TCGA-55-A4-94,.}","{tcga-55-a4-94,.}","{NN,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_3,"? .","{?,.}","{?,.}","{NN,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_4,"O1A-PR Redacted lllillilllllllllllllll illiiiiiiiiiillliiliiiiiliilliiiiiiiiiliillluulmulul Illilllillilillllllllillllilllilllllllllll","{O1A-PR,Redacted,lllillilllllllllllllll,illiiiiiiiiiillliiliiiiiliilliiiiiiiiiliillluulmulul,Illilllillilillllllllillllilllilllllllllll}","{o1a-pr,redacted,lllillilllllllllllllll,illiiiiiiiiiillliiliiiiiliilliiiiiiiiiliillluulmulul,illilllillilillllllllillllilllilllllllllll}","{NN,JJ,NN,NN,NN}","{0,3,1,5,1}","{}"
TCGA-55-A494, TCGA-55-A494SENT_5,"Iillllllllllllillllll","{Iillllllllllllillllll}","{iillllllllllllillllll}","{NN}","{0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_6,".","{.}","{.}","{.}","{0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_7,".","{.}","{.}","{.}","{0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_8,".","{.}","{.}","{.}","{0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_9,"SURGICAL PATHOLOGY REPORT "" "" '","{SURGICAL,PATHOLOGY,REPORT,""\"""",""\"""",'}","{surgical,pathology,report,""\"""",""\"""",'}","{JJ,NN,NN,'',``,''}","{3,3,5,3,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_10,"ADDENDUM REPORT ? * ""","{ADDENDUM,REPORT,?,*,""\""""}","{ADDENDUM,REPORT,?,*,""\""""}","{NNP,NNP,VBD,CD,''}","{2,3,0,3,3}","{}"
TCGA-55-A494, TCGA-55-A494SENT_11,"LU ? ? ? QANCER My !","{LU,?,?,?,QANCER,My,!}","{LU,?,?,?,QANCER,my,!}","{NNP,CD,CD,CD,NNP,PRP$,.}","{0,1,4,5,1,5,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_12,"Agggzg EAQEL SPECiMEN sounce : LUNG LOBECTOMY 3 CD ? O ? 3 SPECWIENIBLOCK NUMBER ? o. demo C_oJ ? Q } no rho ? NOS ZNOY3","{Agggzg,EAQEL,SPECiMEN,sounce,:,LUNG,LOBECTOMY,3,CD,?,O,?,3,SPECWIENIBLOCK,NUMBER,?,o.,demo,C_oJ,?,Q,""}"",no,rho,?,NOS,ZNOY3}","{Agggzg,EAQEL,specimen,sounce,:,lung,lobectomy,3,CD,?,o,?,3,specwieniblock,number,?,o.,demo,c_oj,?,Q,""}"",no,rho,?,no,znoy3}","{NNP,NNP,NN,NN,:,NN,NN,CD,NNP,CD,NN,CD,CD,NN,NN,CD,NN,NN,NN,CD,NNP,CD,DT,NN,CD,NN,NN}","{4,4,4,0,0,7,4,7,21,11,9,13,18,18,18,18,18,11,21,19,4,21,27,27,27,27,21}","{}"
TCGA-55-A494, TCGA-55-A494SENT_13,"I","{I}","{I}","{PRP}","{0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_14,"EGFR Mutation : NOT DETECTED ? .","{EGFR,Mutation,:,NOT,DETECTED,?,.}","{egfr,mutation,:,not,detect,?,.}","{NN,NN,:,RB,VBN,NN,.}","{2,5,0,5,0,5,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_15,".","{.}","{.}","{.}","{0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_16,"Results reviewed by S \ \ < ? .","{Results,reviewed,by,S,""\\"",""\\"",<,?,.}","{result,review,by,s,""\\"",""\\"",<,?,.}","{NNS,VBN,IN,NN,CD,NN,JJR,CD,.}","{2,0,0,2,6,7,4,2,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_17,"? iU \ r \ 5 , iibuo?r zo C / ?wt -.3 The following polymorphism was detected : 2361g > A. C ; - H - ,2 ? 4 ) Sequencing of the entire coding region and splice junction sites of axons 18-21 of the EGFR gene revealed no previously published mutations or any sequence changes that could result in amino acid changes .","{?,iU,""\\"",r,""\\"",5,"","",iibuo?r,zo,C,/,?wt,-.3,The,following,polymorphism,was,detected,:,2361g,>,A.,C,;,-,H,-,"",2"",?,4,),Sequencing,of,the,entire,coding,region,and,splice,junction,sites,of,axons,18-21,of,the,EGFR,gene,revealed,no,previously,published,mutations,or,any,sequence,changes,that,could,result,in,amino,acid,changes,.}","{?,iu,""\\"",r,""\\"",5,"","",iibuo?r,zo,c,/,?wt,-.3,the,follow,polymorphism,be,detect,:,2361g,>,a.,c,;,-,h,-,"",2"",?,4,),sequencing,of,the,entire,coding,region,and,splice,junction,site,of,axon,18-21,of,the,egfr,gene,reveal,no,previously,publish,mutation,or,any,sequence,change,that,could,result,in,amino,acid,change,.}","{NN,NN,CD,NN,NN,CD,"","",NN,NN,NN,:,NN,CD,DT,VBG,NN,VBD,VBN,:,JJ,JJR,NN,NN,:,:,NN,:,CD,CD,CD,CD,NN,IN,DT,JJ,NN,NN,CC,NN,NN,NNS,IN,NNS,CD,IN,DT,NN,NN,VBD,DT,RB,VBN,NNS,CC,DT,NN,NNS,WDT,MD,VB,IN,NN,NN,NNS,.}","{2,49,5,5,2,5,0,10,10,5,12,10,12,16,16,18,18,10,0,10,23,23,20,0,0,2,0,29,26,31,32,41,0,37,37,37,32,0,32,41,44,0,41,26,0,48,48,26,0,53,52,53,49,0,57,57,53,60,60,57,0,64,64,60,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_18,"However , one or more polymorphic sequence changes were discovered in the EGFR gene .","{However,"","",one,or,more,polymorphic,sequence,changes,were,discovered,in,the,EGFR,gene,.}","{however,"","",one,or,more,polymorphic,sequence,change,be,discover,in,the,egfr,gene,.}","{RB,"","",CD,CC,JJR,JJ,NN,NNS,VBD,VBN,IN,DT,NN,NN,.}","{10,0,8,0,8,8,8,10,10,0,0,14,14,10,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_19,"These polymorphisms are interpreted as non-pathogenic because they do not lead to amino acid changes .","{These,polymorphisms,are,interpreted,as,non-pathogenic,because,they,do,not,lead,to,amino,acid,changes,.}","{these,polymorphism,be,interpret,as,non-pathogenic,because,they,do,not,lead,to,amino,acid,change,.}","{DT,NNS,VBP,VBN,IN,JJ,IN,PRP,VBP,RB,VB,TO,NN,NN,NNS,.}","{2,4,4,0,0,4,11,11,11,11,4,0,15,15,11,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_20,"These polymorphisms are not expected to have any clinical signi?cance .","{These,polymorphisms,are,not,expected,to,have,any,clinical,signi?cance,.}","{these,polymorphism,be,not,expect,to,have,any,clinical,signi?cance,.}","{DT,NNS,VBP,RB,VBN,TO,VB,DT,JJ,NN,.}","{2,5,5,5,0,7,5,10,10,7,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_21,"As 7 % of patients who respond to EGFR inhibitors do not show mutations in exons 18-21 of EGFR gene , a negative result does not preclude the possibility of a cliniml rasponse to EGFR inhibitors .","{As,7,%,of,patients,who,respond,to,EGFR,inhibitors,do,not,show,mutations,in,exons,18-21,of,EGFR,gene,"","",a,negative,result,does,not,preclude,the,possibility,of,a,cliniml,rasponse,to,EGFR,inhibitors,.}","{as,7,%,of,patient,who,respond,to,egfr,inhibitor,do,not,show,mutation,in,exon,18-21,of,egfr,gene,"","",a,negative,result,do,not,preclude,the,possibility,of,a,cliniml,rasponse,to,egfr,inhibitor,.}","{IN,CD,NN,IN,NNS,WP,VBP,TO,NN,NNS,VBP,RB,VB,NNS,IN,NNS,CD,IN,NN,NN,"","",DT,JJ,NN,VBZ,RB,VB,DT,NN,IN,DT,NN,NN,TO,NN,NNS,.}","{13,3,13,0,3,7,5,0,10,7,13,13,27,13,0,13,16,0,20,16,0,24,24,27,27,27,0,29,27,0,33,33,29,0,36,27,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_22,"? KRAS Mutation : DETECTED ( Abnormal ) Results reviewed by Based on sequence analysis , K-Ra : codon 12 GGT > GAT ( G12D ) mutant was detected .","{?,KRAS,Mutation,:,DETECTED,(,Abnormal,),Results,reviewed,by,Based,on,sequence,analysis,"","",K-Ra,:,codon,12,GGT,>,GAT,(,G12D,),mutant,was,detected,.}","{?,KRAS,mutation,:,detect,(,abnormal,),result,review,by,base,on,sequence,analysis,"","",k-ra,:,codon,12,GGT,>,gat,(,g12d,),mutant,be,detect,.}","{RB,NNP,NN,:,VBN,CD,JJ,NN,NNS,VBN,IN,VBN,IN,NN,NN,"","",NN,:,NN,CD,NNP,JJR,NN,CD,NN,NN,NN,VBD,VBN,.}","{2,3,5,0,29,9,9,9,5,9,10,0,10,15,10,0,15,0,21,21,9,23,21,27,27,27,29,29,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_23,"Lung Ca ( NSCLC ) .","{Lung,Ca,(,NSCLC,),.}","{lung,ca,(,nsclc,),.}","{NN,NN,CD,NN,NN,.}","{2,0,5,5,2,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_24,"Ai .","{Ai,.}","{aus,.}","{NN,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_25,"i < .","{i,<,.}","{i,<,.}","{LS,JJR,.}","{2,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_26,"FiSH : SEE BELOW Specimen Type : Parai?n Embedded Tumor Tissue Clinical indication : FlSH study for oncology Meihod : FISH Total Coils : 50 images Captured ; 2 RESULT : NEGATIVE FDR ALK REARRANGEMENT [ SEE COMMENT BELOW ] NTERPRETATION ; Fluorescence in silo hybridization ( FlSH ) analysis did not reveal a rearrangement of the ALK gene .","{FiSH,:,SEE,BELOW,Specimen,Type,:,Parai?n,Embedded,Tumor,Tissue,Clinical,indication,:,FlSH,study,for,oncology,Meihod,:,FISH,Total,Coils,:,50,images,Captured,;,2,RESULT,:,NEGATIVE,FDR,ALK,REARRANGEMENT,[,SEE,COMMENT,BELOW,],NTERPRETATION,;,Fluorescence,in,silo,hybridization,(,FlSH,),analysis,did,not,reveal,a,rearrangement,of,the,ALK,gene,.}","{fish,:,see,below,Specimen,type,:,Parai?n,embed,tumor,tissue,clinical,indication,:,flsh,study,for,oncology,Meihod,:,fish,total,coil,:,50,image,capture,;,2,result,:,NEGATIVE,FDR,ALK,REARRANGEMENT,[,see,comment,below,],nterpretation,;,fluorescence,in,silo,hybridization,(,flsh,),analysis,do,not,reveal,a,rearrangement,of,the,alk,gene,.}","{NN,:,VB,IN,NNP,NN,:,NNP,VBD,NN,NN,JJ,NN,:,NN,NN,IN,NN,NNP,:,NN,JJ,NNS,:,CD,NNS,VBN,:,CD,NN,:,NNP,NNP,NNP,NNP,CD,VBP,JJ,IN,CD,NN,:,NN,IN,NN,NN,CD,NN,NN,NN,VBD,RB,VB,DT,NN,IN,DT,NN,NN,.}","{0,0,1,0,6,3,0,9,3,11,9,13,11,0,16,11,0,19,16,0,11,23,21,0,26,11,26,0,30,11,0,35,35,35,37,35,30,37,0,41,37,0,3,0,46,43,50,50,50,53,53,53,46,55,53,0,59,59,55,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_27,"However , 1-3 additional copies of the ALK region were observed in 80 % of cells .","{However,"","",1-3,additional,copies,of,the,ALK,region,were,observed,in,80,%,of,cells,.}","{however,"","",1-3,additional,copy,of,the,alk,region,be,observe,in,80,%,of,cell,.}","{RB,"","",CD,JJ,NNS,IN,DT,NN,NN,VBD,VBN,IN,CD,NN,IN,NNS,.}","{11,0,5,5,11,0,9,9,5,11,0,0,14,11,0,14,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_28,"The signi?cance of additional copies of the ALK region is not dear .","{The,signi?cance,of,additional,copies,of,the,ALK,region,is,not,dear,.}","{the,signi?cance,of,additional,copy,of,the,alk,region,be,not,dear,.}","{DT,NN,IN,JJ,NNS,IN,DT,NN,NN,VBZ,RB,RB,.}","{2,12,0,5,2,0,9,9,5,12,12,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_29,"[ in nomsmail cell lung carcinoma .","{[,in,nomsmail,cell,lung,carcinoma,.}","{[,in,nomsmail,cell,lung,carcinoma,.}","{NN,IN,JJ,NN,NN,NN,.}","{0,0,6,6,6,1,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_30,"overexpression of the ALK kinasa is seen most commonly through an inversion producing ELM4-ALK fusion protein .","{overexpression,of,the,ALK,kinasa,is,seen,most,commonly,through,an,inversion,producing,ELM4-ALK,fusion,protein,.}","{overexpression,of,the,alk,kinasa,be,see,most,commonly,through,a,inversion,produce,elm4-alk,fusion,protein,.}","{NN,IN,DT,NN,NN,VBZ,VBN,RBS,RB,IN,DT,NN,VBG,NN,NN,NN,.}","{7,0,5,5,1,7,0,9,7,0,12,7,12,16,16,13,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_31,"A small proportion of tumors ( approximately 5 % ) with ALK rearrangement demonstrated by other methods may be missed by this study .","{A,small,proportion,of,tumors,(,approximately,5,%,),with,ALK,rearrangement,demonstrated,by,other,methods,may,be,missed,by,this,study,.}","{a,small,proportion,of,tumor,(,approximately,5,%,),with,alk,rearrangement,demonstrate,by,other,method,may,be,miss,by,this,study,.}","{DT,JJ,NN,IN,NNS,CD,RB,CD,NN,CD,IN,NN,NN,VBN,IN,JJ,NNS,MD,VB,VBN,IN,DT,NN,.}","{3,3,20,0,3,7,20,9,7,20,0,13,10,13,0,17,14,20,20,0,0,23,20,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_32,"This test is indicated as an aid in the assessment of patients for whom crizoiinib ( 3.9 .","{This,test,is,indicated,as,an,aid,in,the,assessment,of,patients,for,whom,crizoiinib,(,3.9,.}","{this,test,be,indicate,as,a,aid,in,the,assessment,of,patient,for,whom,crizoiinib,(,3.9,.}","{DT,NN,VBZ,VBN,IN,DT,NN,IN,DT,NN,IN,NNS,IN,WP,VBP,NN,CD,.}","{2,4,4,0,0,7,4,0,10,7,0,10,0,15,12,15,16,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_33,"XALKORl ) treatment is being considered .","{XALKORl,),treatment,is,being,considered,.}","{xalkorl,),treatment,be,be,consider,.}","{NN,NN,NN,VBZ,VBG,VBN,.}","{3,3,6,6,6,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_34,"Correlation with clinical ?ndings and Cifhel ? 13501 ? atory studies if ? indicated .","{Correlation,with,clinical,?ndings,and,Cifhel,?,13501,?,atory,studies,if,?,indicated,.}","{correlation,with,clinical,?ndings,and,Cifhel,?,13501,?,atory,study,if,?,indicate,.}","{NN,IN,JJ,NNS,CC,NNP,CD,CD,NN,JJ,NNS,IN,NN,VBD,.}","{14,0,4,1,0,11,8,9,10,11,1,13,11,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_35,"Please expect the result of any other concurrent lest in a separate report .","{Please,expect,the,result,of,any,other,concurrent,lest,in,a,separate,report,.}","{please,expect,the,result,of,any,other,concurrent,lest,in,a,separate,report,.}","{VB,VB,DT,NN,IN,DT,JJ,JJ,IN,IN,DT,JJ,NN,.}","{2,0,4,2,0,8,8,4,10,8,13,13,10,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_36,"FISH test was performed using a brealoapart probe specific for the ALK gene l .","{FISH,test,was,performed,using,a,brealoapart,probe,specific,for,the,ALK,gene,l,.}","{fish,test,be,perform,use,a,brealoapart,probe,specific,for,the,alk,gene,l,.}","{NN,NN,VBD,VBN,VBG,DT,NN,NN,JJ,IN,DT,NN,NN,NN,.}","{2,4,4,0,4,8,8,9,5,0,13,13,5,5,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_37,"According to the manufacturer 's directional insert , the cutoifvaiue for ALK rearrangement is 15 % of interphase cells in pam?lwernbedded specimens .","{According,to,the,manufacturer,'s,directional,insert,"","",the,cutoifvaiue,for,ALK,rearrangement,is,15,%,of,interphase,cells,in,pam?lwernbedded,specimens,.}","{accord,to,the,manufacturer,'s,directional,insert,"","",the,cutoifvaiue,for,ALK,rearrangement,be,15,%,of,interphase,cell,in,pam?lwernbedded,specimen,.}","{VBG,TO,DT,NN,POS,JJ,NN,"","",DT,NN,IN,NNP,NN,VBZ,CD,NN,IN,NN,NNS,IN,JJ,NNS,.}","{0,16,4,7,0,7,16,0,10,16,0,13,10,16,16,0,0,19,16,0,22,19,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_38,"This assay has been approved by the U5 .","{This,assay,has,been,approved,by,the,U5,.}","{this,assay,have,be,approve,by,the,u5,.}","{DT,NN,VBZ,VBN,VBN,IN,DT,NN,.}","{2,5,5,5,0,0,8,5,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_39,"Food and Drug Administration .","{Food,and,Drug,Administration,.}","{Food,and,Drug,Administration,.}","{NNP,CC,NNP,NNP,.}","{4,0,4,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_40,"Laboratory resulls reviewed and Clinical interpretation provided by Test performed and reported under supervision c","{Laboratory,resulls,reviewed,and,Clinical,interpretation,provided,by,Test,performed,and,reported,under,supervision,c}","{Laboratory,resull,review,and,clinical,interpretation,provide,by,test,perform,and,report,under,supervision,c}","{NNP,NNS,VBN,CC,JJ,NN,VBN,IN,NN,VBN,CC,VBN,IN,NN,NN}","{2,3,0,0,6,3,6,7,8,9,0,9,0,15,10}","{}"
TCGA-55-A494, TCGA-55-A494SENT_41,"Test performed al ~","{Test,performed,al,~}","{test,perform,al,~}","{NN,VBD,NNP,NNP}","{2,0,4,2}","{}"
TCGA-55-A494, TCGA-55-A494SENT_42,"Addendum Report lmuecl By :","{Addendum,Report,lmuecl,By,:}","{Addendum,Report,lmuecl,by,:}","{NNP,NNP,NN,IN,:}","{3,3,0,3,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_43,"DIAGNOSIS : A Lvel9lymph nodes :","{DIAGNOSIS,:,A,Lvel9lymph,nodes,:}","{diagnosis,:,a,lvel9lymph,node,:}","{NN,:,DT,NN,NNS,:}","{0,0,4,1,1,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_44,"Two benign lymph nodes with nomcaseatlng granulomaiaus in?ammation , see comment ( 0/2 ) .","{Two,benign,lymph,nodes,with,nomcaseatlng,granulomaiaus,in?ammation,"","",see,comment,(,0/2,),.}","{two,benign,lymph,node,with,nomcaseatlng,granulomaiaus,in?ammation,"","",see,comment,(,0/2,),.}","{CD,JJ,NN,NNS,IN,JJ,NN,NN,"","",VBP,NN,CD,CD,NN,.}","{4,4,4,10,0,8,8,4,0,0,10,13,14,11,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_45,"8 .","{8,.}","{8,.}","{CD,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_46,"Level 7 lymph node :","{Level,7,lymph,node,:}","{level,7,lymph,node,:}","{NN,CD,NN,NN,:}","{4,4,4,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_47,"Benign , hyperplasia ( 0/1 ) .","{Benign,"","",hyperplasia,(,0/1,),.}","{benign,"","",hyperplasium,(,0/1,),.}","{JJ,"","",NN,CD,CD,NN,.}","{0,0,1,5,6,3,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_48,"C. Level Blyrnph node :","{C.,Level,Blyrnph,node,:}","{C.,Level,Blyrnph,node,:}","{NNP,NNP,NNP,NN,:}","{4,4,4,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_49,"Benign , hyperplasia .","{Benign,"","",hyperplasia,.}","{benign,"","",hyperplasium,.}","{JJ,"","",NN,.}","{3,0,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_50,"non-caseating granuiomatous in?ammation , see comment ( 011 ) .","{non-caseating,granuiomatous,in?ammation,"","",see,comment,(,011,),.}","{non-caseating,granuiomatous,in?ammation,"","",see,comment,(,011,),.}","{JJ,JJ,NN,"","",VB,NN,NN,CD,NN,.}","{3,3,5,0,0,7,9,9,5,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_51,"D. Right lower lobe of lung lobectomy :","{D.,Right,lower,lobe,of,lung,lobectomy,:}","{D.,Right,lower,lobe,of,lung,lobectomy,:}","{NNP,NNP,JJR,NN,IN,NN,NN,:}","{2,0,4,2,0,7,4,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_52,"Tumor Characteristics : Histologictyps : Ade-nocarcinoma .","{Tumor,Characteristics,:,Histologictyps,:,Ade-nocarcinoma,.}","{tumor,characteristic,:,histologictyp,:,ade-nocarcinoma,.}","{NN,NNS,:,NNS,:,NN,.}","{2,0,0,2,0,4,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_53,"Histologic grade : Moderately differentiated .","{Histologic,grade,:,Moderately,differentiated,.}","{histologic,grade,:,moderately,differentiate,.}","{JJ,NN,:,RB,VBN,.}","{2,5,0,5,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_54,"Tumor site : Peripheral .","{Tumor,site,:,Peripheral,.}","{tumor,site,:,peripheral,.}","{NN,NN,:,JJ,.}","{2,0,0,2,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_55,"Tumor locality : Unifvocal .","{Tumor,locality,:,Unifvocal,.}","{tumor,locality,:,Unifvocal,.}","{NN,NN,:,NNP,.}","{2,0,0,2,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_56,"Tumor size : 3.5 It 3.0 1:11 ) cm .","{Tumor,size,:,3.5,It,3.0,1:11,),cm,.}","{tumor,size,:,3.5,it,3.0,1:11,),cm,.}","{NN,NN,:,CD,PRP,CD,CD,CD,NN,.}","{2,0,0,2,4,7,4,9,7,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_57,"Visceral pleural invasion : Not identi?ed .","{Visceral,pleural,invasion,:,Not,identi?ed,.}","{visceral,pleural,invasion,:,not,identi?ed,.}","{JJ,JJ,NN,:,RB,VBN,.}","{3,3,0,0,6,3,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_58,"Lymphovaacular space invasion : Not identi?ed .","{Lymphovaacular,space,invasion,:,Not,identi?ed,.}","{lymphovaacular,space,invasion,:,not,identi?ed,.}","{JJ,NN,NN,:,RB,VBN,.}","{3,3,0,0,6,3,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_59,"Tumor extension : Nut identi?ed .","{Tumor,extension,:,Nut,identi?ed,.}","{tumor,extension,:,Nut,identi?ed,.}","{NN,NN,:,NNP,NNP,.}","{2,0,0,5,2,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_60,"Treatment affect : Not Identi?ed .","{Treatment,affect,:,Not,Identi?ed,.}","{treatment,affect,:,not,identi?ed,.}","{NN,NN,:,RB,VBN,.}","{2,5,0,5,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_61,"Surgical Margin Status :","{Surgical,Margin,Status,:}","{Surgical,margin,Status,:}","{NNP,NN,NNP,:}","{3,3,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_62,"Tumor distance from bronchial margin : 1.5 cm .","{Tumor,distance,from,bronchial,margin,:,1.5,cm,.}","{tumor,distance,from,bronchial,margin,:,1.5,cm,.}","{NN,NN,IN,JJ,NN,:,CD,NN,.}","{2,0,0,5,2,0,8,2,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_63,"Tumor distance from parenchymal ( stapled ) margin : 1.5 cm .","{Tumor,distance,from,parenchymal,(,stapled,),margin,:,1.5,cm,.}","{tumor,distance,from,parenchymal,(,staple,),margin,:,1.5,cm,.}","{NN,NN,IN,JJ,NN,VBD,CD,NN,:,CD,NN,.}","{2,6,0,5,2,0,8,6,0,11,8,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_64,"Tumor distance from pleural surface : Less than 0.1 cm .","{Tumor,distance,from,pleural,surface,:,Less,than,0.1,cm,.}","{tumor,distance,from,pleural,surface,:,less,than,0.1,cm,.}","{NN,NN,IN,JJ,NN,:,RBR,IN,CD,NN,.}","{2,0,0,5,2,0,2,0,10,7,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_65,"Lymph Node Status ( utilizing all specimens ) :","{Lymph,Node,Status,(,utilizing,all,specimens,),:}","{Lymph,Node,Status,(,utilize,all,specimen,),:}","{NNP,NNP,NNP,CD,VBG,DT,NNS,NN,:}","{3,3,5,3,0,8,8,5,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_66,"1 .","{1,.}","{1,.}","{LS,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_67,"Total number of lymph nodes received : 8 .","{Total,number,of,lymph,nodes,received,:,8,.}","{total,number,of,lymph,node,receive,:,8,.}","{JJ,NN,IN,NN,NNS,VBD,:,CD,.}","{2,6,0,5,2,0,0,6,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_68,"2 .","{2,.}","{2,.}","{LS,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_69,"Total number of lymph nodes containing metastatic camiioma : None ( O/8 ) .","{Total,number,of,lymph,nodes,containing,metastatic,camiioma,:,None,(,O/8,),.}","{total,number,of,lymph,node,contain,metastatic,camiioma,:,none,(,o/8,),.}","{JJ,NN,IN,NN,NNS,VBG,JJ,NN,:,NN,CD,NN,NN,.}","{2,0,0,5,2,5,8,6,0,2,13,13,10,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_70,"Other :","{Other,:}","{other,:}","{JJ,:}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_71,"1 .","{1,.}","{1,.}","{LS,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_72,"Other signi?cant ?ndings : Block 9 has been submitted for lung carcinoma rnutation evaluation panel .","{Other,signi?cant,?ndings,:,Block,9,has,been,submitted,for,lung,carcinoma,rnutation,evaluation,panel,.}","{other,signi?cant,?ndings,:,Block,9,have,be,submit,for,lung,carcinoma,rnutation,evaluation,panel,.}","{JJ,JJ,NNS,:,NNP,CD,VBZ,VBN,VBN,IN,NN,NN,NN,NN,NN,.}","{3,3,0,0,9,5,9,9,3,0,9,15,15,15,9,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_73,"A further report will follow .","{A,further,report,will,follow,.}","{a,further,report,will,follow,.}","{DT,JJ,NN,MD,VB,.}","{3,3,5,5,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_74,"Non-caseating granulomatous intlamrnation is idanti?ed in several of the lymph nodes , see comment .","{Non-caseating,granulomatous,intlamrnation,is,idanti?ed,in,several,of,the,lymph,nodes,"","",see,comment,.}","{non-caseating,granulomatous,intlamrnation,be,idanti?ed,in,several,of,the,lymph,node,"","",see,comment,.}","{JJ,JJ,NN,VBZ,VBN,IN,JJ,IN,DT,NN,NNS,"","",VBP,NN,.}","{3,3,5,5,0,0,5,0,11,11,7,0,7,13,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_75,"Mild to moderate chronic bronchitis and patchy areas of ?brosis are noted .","{Mild,to,moderate,chronic,bronchitis,and,patchy,areas,of,?brosis,are,noted,.}","{mild,to,moderate,chronic,bronchitis,and,patchy,area,of,?brosis,be,note,.}","{JJ,TO,JJ,JJ,NN,CC,JJ,NNS,IN,NN,VBP,VBN,.}","{3,3,5,5,12,0,8,12,0,5,12,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_76,"2 .","{2,.}","{2,.}","{LS,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_77,"pTNM stage : pT2 .","{pTNM,stage,:,pT2,.}","{ptnm,stage,:,pt2,.}","{NN,NN,:,NN,.}","{2,0,0,2,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_78,"ND .","{ND,.}","{nd,.}","{NN,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_79,", ? ' N : "" E ? 1S3 "" .","{"","",?,',N,:,""\"""",E,?,1S3,""\"""",.}","{"","",?,',n,:,""\"""",e,?,1s3,""\"""",.}","{"","",NN,'',NN,:,``,NN,CD,NN,'',.}","{0,4,0,0,0,7,4,7,7,9,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_80,"? ~ ' i3 "" .","{?,~,',i3,""\"""",.}","{?,~,',i3,""\"""",.}","{NN,NN,'',JJ,``,.}","{4,4,0,0,4,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_81,"? .","{?,.}","{?,.}","{NN,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_82,"? . ""","{?,.,""\""""}","{?,.,""\""""}","{NN,.,''}","{0,0,1}","{}"
TCGA-55-A494, TCGA-55-A494SENT_83,".","{.}","{.}","{.}","{0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_84,"? * .","{?,*,.}","{?,*,.}","{NN,NN,.}","{0,1,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_85,"? * ? !","{?,*,?,!}","{?,*,?,!}","{NN,CD,NN,.}","{0,3,1,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_86,"\ ? : - *","{""\\"",?,:,-,*}","{""\\"",?,:,-,*}","{NN,CD,:,:,NN}","{5,5,0,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_87,"Electronic Signature :","{Electronic,Signature,:}","{electronic,signature,:}","{JJ,NN,:}","{2,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_88,"COMMENTS : The non-caseating granulornatous inflammation identi?ed in some of the lymph nodes is of uncertain etiology however the possibility of sarcoidosis would be , given the pattern of granuiomas identified , at the top of the list followed by infection .","{COMMENTS,:,The,non-caseating,granulornatous,inflammation,identi?ed,in,some,of,the,lymph,nodes,is,of,uncertain,etiology,however,the,possibility,of,sarcoidosis,would,be,"","",given,the,pattern,of,granuiomas,identified,"","",at,the,top,of,the,list,followed,by,infection,.}","{comment,:,the,non-caseating,granulornatous,inflammation,identi?ed,in,some,of,the,lymph,node,be,of,uncertain,etiology,however,the,possibility,of,sarcoidosis,would,be,"","",give,the,pattern,of,granuioma,identify,"","",at,the,top,of,the,list,follow,by,infection,.}","{NNS,:,DT,JJ,JJ,NN,VBN,IN,DT,IN,DT,NN,NNS,VBZ,IN,JJ,NN,RB,DT,NN,IN,NN,MD,VB,"","",VBN,DT,NN,IN,NNS,VBN,"","",IN,DT,NN,IN,DT,NN,VBN,IN,NN,.}","{0,0,6,6,6,1,6,0,7,0,12,9,14,12,0,17,14,24,20,24,0,20,24,14,0,7,28,26,0,28,30,0,0,35,7,0,38,35,38,0,39,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_89,"Clinical correlation is suggested .","{Clinical,correlation,is,suggested,.}","{clinical,correlation,be,suggest,.}","{JJ,NN,VBZ,VBN,.}","{2,4,4,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_90,"CUNICAL HlSTClRY : Preoperative Diagnosis : ylc rlth right lung mass Postoperative Diagnosis : Symptomsl?adiologic Findings :","{CUNICAL,HlSTClRY,:,Preoperative,Diagnosis,:,ylc,rlth,right,lung,mass,Postoperative,Diagnosis,:,Symptomsl?adiologic,Findings,:}","{CUNICAL,HlSTClRY,:,Preoperative,diagnosis,:,ylc,rlth,right,lung,mass,postoperative,diagnosis,:,symptomsl?adiologic,finding,:}","{NNP,NNP,:,NNP,NN,:,NN,NN,NN,NN,NN,JJ,NN,:,JJ,NNS,:}","{2,0,0,5,2,0,13,13,13,13,13,13,5,0,16,13,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_91,"SPECIMENS : A. Level 9 lymph node 5 .","{SPECIMENS,:,A.,Level,9,lymph,node,5,.}","{specimen,:,a.,Level,9,lymph,node,5,.}","{NNS,:,NN,NNP,CD,NN,NN,CD,.}","{0,0,1,6,6,3,3,7,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_92,"Level 7 lymph node C. Level 8 lymph node D. Right lower lobe '","{Level,7,lymph,node,C.,Level,8,lymph,node,D.,Right,lower,lobe,'}","{level,7,lymph,node,C.,Level,8,lymph,node,D.,Right,lower,lobe,'}","{NN,CD,NN,NN,NNP,NNP,CD,NN,NN,NNP,NNP,JJR,NN,''}","{4,4,4,12,6,4,8,6,11,11,12,0,12,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_93,"SPEGlME .","{SPEGlME,.}","{speglme,.}","{NN,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_94,"N5 ~ Dl ? i.","{N5,~,Dl,?,i.}","{n5,~,dl,?,i.}","{NN,CD,NN,CD,NN}","{0,3,1,5,1}","{}"
TCGA-55-A494, TCGA-55-A494SENT_95,"GROSS DESCRIPTION : The specimen is received in four formalin ?lled containers labeled with the patienrsname","{GROSS,DESCRIPTION,:,The,specimen,is,received,in,four,formalin,?lled,containers,labeled,with,the,patienrsname}","{gross,description,:,the,specimen,be,receive,in,four,formalin,?lled,container,label,with,the,patienrsname}","{JJ,NN,:,DT,NN,VBZ,VBN,IN,CD,NN,VBD,NNS,VBN,IN,DT,NN}","{2,0,0,5,7,7,2,0,10,7,10,11,12,0,16,13}","{}"
TCGA-55-A494, TCGA-55-A494SENT_96,"A. Container A is additionally labeled ? level 9 lymph node ? and contains two gray-black rubbery nodules consistent with anthracotic lymph nodes .","{A.,Container,A,is,additionally,labeled,?,level,9,lymph,node,?,and,contains,two,gray-black,rubbery,nodules,consistent,with,anthracotic,lymph,nodes,.}","{a.,Container,A,be,additionally,label,?,level,9,lymph,node,?,and,contain,two,gray-black,rubbery,nodule,consistent,with,anthracotic,lymph,node,.}","{NN,NNP,NNP,VBZ,RB,VBN,JJ,NN,CD,NN,NN,NN,CC,VBZ,CD,JJ,JJ,NNS,JJ,IN,JJ,NN,NNS,.}","{3,3,14,6,6,0,12,12,12,12,12,6,0,6,18,18,18,14,14,0,23,23,19,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_97,"They are 0.5 and 1.7 cm in greatest dimension .","{They,are,0.5,and,1.7,cm,in,greatest,dimension,.}","{they,be,0.5,and,1.7,cm,in,greatest,dimension,.}","{PRP,VBP,CD,CC,CD,NN,IN,JJS,NN,.}","{6,6,6,0,6,0,0,9,6,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_98,"The largest nodule is inked and bisected and au tissue is submitted in cassette A1 labeled B. Container 3 is additionally labeled ? level 7 lymph node ? and contains a 1.5 cm purple-gray nodule consistent with lymph node .","{The,largest,nodule,is,inked,and,bisected,and,au,tissue,is,submitted,in,cassette,A1,labeled,B.,Container,3,is,additionally,labeled,?,level,7,lymph,node,?,and,contains,a,1.5,cm,purple-gray,nodule,consistent,with,lymph,node,.}","{the,largest,nodule,be,ink,and,bisect,and,au,tissue,be,submit,in,cassette,a1,label,B.,Container,3,be,additionally,label,?,level,7,lymph,node,?,and,contain,a,1.5,cm,purple-gray,nodule,consistent,with,lymph,node,.}","{DT,JJS,NN,VBZ,VBN,CC,VBN,CC,NN,NN,VBZ,VBN,IN,NN,NN,VBN,NNP,NNP,CD,VBZ,RB,VBN,JJ,NN,CD,NN,NN,NN,CC,VBZ,DT,CD,NN,NN,NN,JJ,IN,NN,NN,.}","{3,3,7,5,0,0,5,0,10,30,12,5,0,15,12,15,18,22,18,22,22,16,28,28,28,28,28,22,0,12,35,35,35,35,36,30,0,39,36,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_99,"The specimen is sectioned and entirely submitted in cassette 81 labels :","{The,specimen,is,sectioned,and,entirely,submitted,in,cassette,81,labels,:}","{the,specimen,be,section,and,entirely,submit,in,cassette,81,label,:}","{DT,NN,VBZ,VBN,CC,RB,VBN,IN,NN,CD,NNS,:}","{2,7,4,0,0,7,4,0,11,11,7,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_100,"C. Container o is additionally labeled ? level 8 lymph node ? and contains a 3.5 x 2.3 x 1.0 cm gray-black rubbenr nodule consistent with anlhracotic lymph node .","{C.,Container,o,is,additionally,labeled,?,level,8,lymph,node,?,and,contains,a,3.5,x,2.3,x,1.0,cm,gray-black,rubbenr,nodule,consistent,with,anlhracotic,lymph,node,.}","{C.,Container,o,be,additionally,label,?,level,8,lymph,node,?,and,contain,a,3.5,x,2.3,x,1.0,cm,gray-black,rubbenr,nodule,consistent,with,anlhracotic,lymph,node,.}","{NNP,NNP,NN,VBZ,RB,VBN,JJ,NN,CD,NN,NN,NN,CC,VBZ,DT,CD,CC,CD,CC,CD,NN,NN,NN,NN,JJ,IN,JJ,NN,NN,.}","{3,3,14,6,6,0,12,12,12,12,12,6,0,6,16,18,0,14,0,21,18,24,24,6,24,0,29,29,25,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_101,"The specimen is serially sectioned and entirely submitted in cassettes C1 through 4 labelec D , Container D is additionally labeled ? right lower lobe ? and contains 11.5 x 11.0 x 7.0 cm long labs .","{The,specimen,is,serially,sectioned,and,entirely,submitted,in,cassettes,C1,through,4,labelec,D,"","",Container,D,is,additionally,labeled,?,right,lower,lobe,?,and,contains,11.5,x,11.0,x,7.0,cm,long,labs,.}","{the,specimen,be,serially,section,and,entirely,submit,in,cassette,c1,through,4,labelec,d,"","",Container,D,be,additionally,label,?,right,lower,lobe,?,and,contain,11.5,x,11.0,x,7.0,cm,long,lab,.}","{DT,NN,VBZ,RB,VBN,CC,RB,VBN,IN,NNS,NN,IN,CD,NN,NN,"","",NNP,NNP,VBZ,RB,VBN,RB,RB,JJR,NN,NN,CC,VBZ,CD,CC,CD,CC,CD,NN,RB,NNS,.}","{2,5,5,5,21,0,8,5,0,11,8,0,15,15,8,0,18,28,21,21,0,21,22,26,26,22,0,21,28,0,28,0,34,35,36,28,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_102,"The pleura is purple-gray anthracotic .","{The,pleura,is,purple-gray,anthracotic,.}","{the,pleuron,be,purple-gray,anthracotic,.}","{DT,NN,VBZ,JJ,JJ,.}","{2,5,5,5,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_103,"A 10.5 cm in length serpiginous staole line is present The pleura is remarkable for a 3.0 x 2.5 cm yellow-tan plaque like lesion and area of umbiiication consistent with tumor .","{A,10.5,cm,in,length,serpiginous,staole,line,is,present,The,pleura,is,remarkable,for,a,3.0,x,2.5,cm,yellow-tan,plaque,like,lesion,and,area,of,umbiiication,consistent,with,tumor,.}","{a,10.5,cm,in,length,serpiginous,staole,line,be,present,the,pleuron,be,remarkable,for,a,3.0,x,2.5,cm,yellow-tan,plaque,like,lesion,and,area,of,umbiiication,consistent,with,tumor,.}","{DT,CD,NN,IN,NN,JJ,NN,NN,VBZ,JJ,DT,NN,VBZ,JJ,IN,DT,CD,CC,CD,NN,NN,NN,IN,NN,CC,NN,IN,NN,JJ,IN,NN,.}","{3,3,10,0,8,8,8,3,10,0,12,14,14,10,0,17,14,0,22,22,22,14,0,22,0,24,0,24,28,0,29,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_104,"This area is inked blue .","{This,area,is,inked,blue,.}","{this,area,be,ink,blue,.}","{DT,NN,VBZ,VBN,JJ,.}","{2,4,4,0,4,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_105,"The staple line is removed and the underlying parenchyma is beefy red and glistening with no discrete lesions .","{The,staple,line,is,removed,and,the,underlying,parenchyma,is,beefy,red,and,glistening,with,no,discrete,lesions,.}","{the,staple,line,be,remove,and,the,underlie,parenchyma,be,beefy,red,and,glisten,with,no,discrete,lesion,.}","{DT,NN,NN,VBZ,VBN,CC,DT,VBG,NN,VBZ,JJ,JJ,CC,VBG,IN,DT,JJ,NNS,.}","{3,3,5,5,0,0,9,9,14,12,12,5,0,5,0,18,18,14,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_106,"Exposed vascular margins are present , as well as a 0.6 cm in length x 0.9 an in diameter bronchial margin .","{Exposed,vascular,margins,are,present,"","",as,well,as,a,0.6,cm,in,length,x,0.9,an,in,diameter,bronchial,margin,.}","{expose,vascular,margin,be,present,"","",as,well,as,a,0.6,cm,in,length,x,0.9,a,in,diameter,bronchial,margin,.}","{VBN,JJ,NNS,VBP,JJ,"","",RB,RB,IN,DT,CD,NN,IN,NN,CC,CD,DT,IN,NN,JJ,NN,.}","{0,3,1,5,3,0,0,0,0,12,12,1,0,12,0,3,21,19,21,21,16,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_107,"Additional small bronchiole margins are present within the exposed parenchyma .","{Additional,small,bronchiole,margins,are,present,within,the,exposed,parenchyma,.}","{additional,small,bronchiole,margin,be,present,within,the,expose,parenchyma,.}","{JJ,JJ,NN,NNS,VBP,JJ,IN,DT,VBN,NN,.}","{4,4,4,6,6,0,0,10,10,6,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_108,"The largest bronchus is opened to reveal a clear mucoid intraluminal substance .","{The,largest,bronchus,is,opened,to,reveal,a,clear,mucoid,intraluminal,substance,.}","{the,largest,bronchus,be,open,to,reveal,a,clear,mucoid,intraluminal,substance,.}","{DT,JJS,NNS,VBZ,VBN,TO,VB,DT,JJ,JJ,JJ,NN,.}","{3,3,5,5,0,7,5,12,10,12,12,7,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_109,"The endothelium is yellow ~ tan and striated with no discrete lesions .","{The,endothelium,is,yellow,~,tan,and,striated,with,no,discrete,lesions,.}","{the,endothelium,be,yellow,~,tan,and,striate,with,no,discrete,lesion,.}","{DT,NN,VBZ,JJ,NN,NN,CC,VBN,IN,DT,JJ,NNS,.}","{2,8,6,6,6,0,0,6,0,12,12,8,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_110,"The specimen is serially sectioned to reveal a 3.5 X 3.0 x 1.0 cm ill-de?ned gray-white mass abutting the pleura at the site of umbllication and approaching to within 1.5 cm of both the bronchial and paranchymal margins .","{The,specimen,is,serially,sectioned,to,reveal,a,3.5,X,3.0,x,1.0,cm,ill-de?ned,gray-white,mass,abutting,the,pleura,at,the,site,of,umbllication,and,approaching,to,within,1.5,cm,of,both,the,bronchial,and,paranchymal,margins,.}","{the,specimen,be,serially,section,to,reveal,a,3.5,x,3.0,x,1.0,cm,ill-de?ned,gray-white,mass,abut,the,pleuron,at,the,site,of,umbllication,and,approach,to,within,1.5,cm,of,both,the,bronchial,and,paranchymal,margin,.}","{DT,NN,VBZ,RB,VBN,TO,VB,DT,CD,NN,CD,CC,CD,NN,JJ,JJ,NN,VBG,DT,NN,IN,DT,NN,IN,NN,CC,VBG,TO,IN,CD,NN,IN,CC,DT,JJ,CC,JJ,NNS,.}","{2,5,5,5,0,7,5,10,10,7,10,0,14,10,17,17,14,7,20,18,0,23,18,0,23,0,18,27,0,31,27,0,35,35,31,0,38,31,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_111,"The remainder of the paranchyma is pink-tan spongy and congested with no additional lesions .","{The,remainder,of,the,paranchyma,is,pink-tan,spongy,and,congested,with,no,additional,lesions,.}","{the,remainder,of,the,paranchyma,be,pink-tan,spongy,and,congest,with,no,additional,lesion,.}","{DT,NN,IN,DT,NN,VBZ,JJ,JJ,CC,VBN,IN,DT,JJ,NNS,.}","{2,8,0,5,2,8,8,0,0,8,0,14,14,10,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_112,"Four black anthracotlc parabronchial nodules are identi?ed consistent with lvmnh nndrw 11-res .","{Four,black,anthracotlc,parabronchial,nodules,are,identi?ed,consistent,with,lvmnh,nndrw,11-res,.}","{four,black,anthracotlc,parabronchial,nodule,be,identi?ed,consistent,with,lvmnh,nndrw,11-re,.}","{CD,JJ,NN,JJ,NNS,VBP,VBN,JJ,IN,NN,NN,NNS,.}","{5,5,5,5,7,7,0,7,0,12,12,7,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_113,"ragga from 0.4 up to 0.9 cm in greatest dimension .","{ragga,from,0.4,up,to,0.9,cm,in,greatest,dimension,.}","{ragga,from,0.4,up,to,0.9,cm,in,greatest,dimension,.}","{NN,IN,CD,IN,TO,CD,NN,IN,JJS,NN,.}","{0,0,1,1,0,7,4,0,10,7,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_114,"Representative sections are submitted in cassettes 01 through 11 labeled leslgnated as follows : D1 and 2 , bronchiole and vascular margins to include largest bronchial margin in cassette D2 : cassette D3 , mired , parencnyrnal margin .","{Representative,sections,are,submitted,in,cassettes,01,through,11,labeled,leslgnated,as,follows,:,D1,and,2,"","",bronchiole,and,vascular,margins,to,include,largest,bronchial,margin,in,cassette,D2,:,cassette,D3,"","",mired,"","",parencnyrnal,margin,.}","{Representative,section,be,submit,in,cassette,01,through,11,label,leslgnate,as,follow,:,d1,and,2,"","",bronchiole,and,vascular,margin,to,include,largest,bronchial,margin,in,cassette,d2,:,cassette,d3,"","",mire,"","",parencnyrnal,margin,.}","{NNP,NNS,VBP,VBN,IN,NNS,CD,IN,CD,VBN,VBN,IN,VBZ,:,NN,CC,CD,"","",NN,CC,JJ,NNS,TO,VB,JJS,JJ,NN,IN,NN,NN,:,NN,NN,"","",VBN,"","",JJ,NN,.}","{2,4,4,0,0,4,4,0,4,9,10,13,11,0,24,0,24,0,17,0,22,17,24,13,26,27,24,0,30,24,0,33,38,0,33,0,38,4,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_115,"perpendicular .","{perpendicular,.}","{perpendicular,.}","{JJ,.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_116,"04 through 8 .","{04,through,8,.}","{04,through,8,.}","{NN,IN,CD,.}","{0,0,1,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_117,"mass to inked pleura ; 9 and 10 , additional mass : 11 .","{mass,to,inked,pleura,;,9,and,10,"","",additional,mass,:,11,.}","{mass,to,ink,pleuron,;,9,and,10,"","",additional,mass,:,11,.}","{NN,TO,VBN,NN,:,CD,CC,CD,"","",JJ,NN,:,CD,.}","{0,3,1,3,0,1,0,1,0,11,6,0,6,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_118,"four whole possible parabronchial lymph nodes .","{four,whole,possible,parabronchial,lymph,nodes,.}","{four,whole,possible,parabronchial,lymph,node,.}","{CD,JJ,JJ,JJ,NN,NNS,.}","{0,6,6,6,6,1,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_119,"Additionally , a yellow .","{Additionally,"","",a,yellow,.}","{additionally,"","",a,yellow,.}","{RB,"","",DT,JJ,.}","{0,0,4,1,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_120,"green and blue cassette are submitted for genomics research each labeled","{green,and,blue,cassette,are,submitted,for,genomics,research,each,labeled}","{green,and,blue,cassette,be,submit,for,genomic,research,each,label}","{JJ,CC,JJ,NN,VBP,VBN,IN,NNS,NN,DT,VBN}","{4,0,1,6,6,0,0,9,6,9,9}","{}"
TCGA-55-A494, TCGA-55-A494SENT_121,"MICROSCOPIC EXAMINATION : Special stains for aoid ? fast bacilli and fungi done selectively on the Level 9 lmph node dmonsmm_ggm L?. , , .","{MICROSCOPIC,EXAMINATION,:,Special,stains,for,aoid,?,fast,bacilli,and,fungi,done,selectively,on,the,Level,9,lmph,node,dmonsmm_ggm,L?.,"","","","",.}","{microscopic,examination,:,special,stain,for,aoid,?,fast,bacillus,and,fungus,do,selectively,on,the,Level,9,lmph,node,dmonsmm_ggm,l?.,"","","","",.}","{JJ,NN,:,JJ,NNS,IN,JJ,NN,JJ,NNS,CC,NNS,VBN,RB,IN,DT,NNP,CD,NN,NN,NN,NN,"","","","",.}","{2,0,0,5,2,0,10,10,10,5,0,10,12,13,0,21,21,21,21,21,13,13,0,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_122,"- , .","{-,"","",.}","{-,"","",.}","{:,"","",.}","{0,0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_123,", .","{"","",.}","{"","",.}","{"","",.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_124,".","{.}","{.}","{.}","{0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_125,", .","{"","",.}","{"","",.}","{"","",.}","{0,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_126,".","{.}","{.}","{.}","{0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_127,"Criteria Didgllusis D : srrepan _ \ .","{Criteria,Didgllusis,D,:,srrepan,_,""\\"",.}","{criterion,didgllusis,d,:,srrepan,_,""\\"",.}","{NNS,NN,NN,:,VB,CD,CD,.}","{3,3,0,0,3,7,5,0}","{}"
TCGA-55-A494, TCGA-55-A494SENT_128,"L _ Primary Tumor site Dim epnncy HIPAA Discrepancy Pnar Malignancy uismy","{L,_,Primary,Tumor,site,Dim,epnncy,HIPAA,Discrepancy,Pnar,Malignancy,uismy}","{l,_,primary,tumor,site,dim,epnncy,HIPAA,Discrepancy,Pnar,malignancy,uismy}","{NN,CD,JJ,NN,NN,JJ,NN,NNP,NNP,NNP,NN,NN}","{0,5,5,5,1,7,5,12,12,12,12,1}","{}"
